MSTR three-lens brief
Evidence-based stock research on MSTR. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Moved +3.52% yesterday. · Trading at 4% of its 52-week range — deep in the lower band.
- Moved +3.52% yesterday.
- Trading at 4% of its 52-week range — deep in the lower band.
- 50-day MA below 200-day MA (death-cross regime); price below both.
- Underperforming SPY by 37.3pp over 30 days.
- Currently unprofitable on a trailing basis — no P/E multiple available.
MSTR closed at $97.19 (+3.52%) as of 2026-07-10. Market cap: $34.77B. Price is below the 50-day MA and below the 200-day MA. Positives: moved +3.52% yesterday.; analyst mean target $303.64 — 212% above current (14 analysts).. Concerns: trading at 4% of its 52-week range — deep in the lower band.; 50-day MA below 200-day MA (death-cross regime); price below both.. Last quarter: Revenue $124.30M, net income -$12.77B, free cash flow -$8.70B. Watching for: 2026-07-30 earnings release (19 days out).
Why three lenses on MSTR, not one.
A single reasoning model has blind spots it doesn’t know about. We examine MSTRacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/MSTR" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath MSTR brief"></iframe>